Phio Pharmaceuticals Corp.
PHIO | NASDAQ
$1.01
-$0.02 (-1.94%)
At close: Sep 21, 2026, 4:00 PM ET
$1.06
+$0.05 (+4.95%)
Pre-market:
Sep 22, 2026, 6:21 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -16.91M | -10.93M | -8.7M | -7.95M | -7.09M | -6.77M | -7.15M | -7.42M | -8.68M | -9.38M | -10.83M | -11.66M | -12.46M | -12.44M | -11.48M | -12.2M | -12.37M | -12.52M | -13.29M | -12.3M | -10.87M | -9.85M |
Depreciation & Amortization | 6K | 4K | 3K | 44K | 42K | 43K | 77K | 78K | 125K | 171K | 184K | 278K | 277K | 279K | 284K | 167K | 140K | 109K | 75K | 72K | 99K | 128K |
Stock-Based Compensation | 1.03M | 482K | 207K | 255K | 194K | 158K | 147K | 108K | 145K | 224K | 303K | 336K | 350K | 339K | 414K | 510K | 550K | 599K | 480K | 368K | 225K | 93K |
Other Working Capital | -1.09M | -366K | 52K | 102K | -139K | 132K | 266K | -1.02M | -476K | -616K | -414K | 425K | 719K | -28K | -1.75M | -623K | -418K | -49K | 1.44M | 386K | -331K | -84K |
Other Non-Cash Items | 268K | 271K | 274K | -51K | -51K | -51K | -48K | 129K | 780K | 780K | 777K | 560K | -696K | -696K | -650K | -529K | 105K | 134K | -116K | -118K | -110K | -109K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -651K | -651K | -651K | -651K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -599K | -532K | 235K | 434K | -239K | 239K | -138K | -1.01M | -782K | -1.2M | -536K | 55K | 817K | 1.15M | -697K | 157K | 336K | -381K | 990K | -34K | -464K | -154K |
Operating Cash Flow | -16.21M | -10.71M | -7.98M | -7.27M | -7.14M | -6.38M | -7.11M | -8.11M | -9.06M | -10.05M | -10.75M | -11.08M | -11.71M | -11.37M | -12.13M | -11.9M | -11.24M | -12.06M | -11.86M | -12.01M | -11.12M | -9.89M |
Capital Expenditures | -7K | -10K | -12K | -13K | -6K | -3K | -1K | n/a | n/a | -5K | -5K | -5K | -12K | -17K | -121K | -121K | -144K | -149K | -51K | -52K | -30K | -15K |
Cash Acquisitions | 3K | 3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 3K | n/a | n/a | 9K | 9K | 9K | 9K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -1K | -7K | -12K | -4K | 3K | 6K | 8K | n/a | n/a | -5K | -5K | -5K | -12K | -17K | -121K | -121K | -144K | -149K | -51K | -52K | -30K | -15K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 233K | 233K | n/a | n/a | -242K | -20K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | -1K | -1K | -5K | -5K | -4K | -4K | -13K | -13K | -16K | -16K | -28K | -29K | -26K | -26K | -1K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -30K | -30K | -30K | -31K | -1K | -1K | -1K | -1K | -1K | -1K | -26K | -25K | -25K | -25K | n/a | n/a | -233K | -233K | 2.15M | 2.15M | 2.38M | 2.38M |
Financial Cash Flow | 14.43M | 14.47M | 23.64M | 12.59M | 13.21M | 13.17M | 4M | 5.04M | 2.4M | 7.45M | 7.41M | 5.01M | 5.01M | -39K | -26K | -29K | -26K | -26K | 21.72M | 21.72M | 21.71M | 29.32M |
Net Cash Flow | -1.78M | 3.75M | 15.65M | 5.32M | 6.08M | 6.8M | -3.11M | -3.07M | -6.66M | -2.61M | -3.34M | -6.08M | -6.71M | -11.42M | -12.28M | -12.05M | -11.41M | -12.24M | 9.81M | 9.66M | 10.56M | 19.41M |
Free Cash Flow | -16.21M | -10.72M | -7.99M | -7.28M | -7.15M | -6.38M | -7.11M | -8.11M | -9.06M | -10.06M | -10.75M | -11.09M | -11.72M | -11.39M | -12.25M | -12.02M | -11.38M | -12.21M | -11.91M | -12.06M | -11.15M | -9.91M |
Adj. Free Cash Flow | -17.24M | -11.2M | -8.2M | -7.54M | -7.34M | -6.54M | -7.26M | -8.22M | -9.2M | -10.28M | -11.06M | -11.43M | -12.07M | -11.72M | -12.66M | -12.53M | -11.93M | -12.81M | -12.39M | -12.43M | -11.37M | -10M |
Maintenance CapEx | -7K | -10K | -12K | -13K | -6K | -3K | -1K | n/a | n/a | -5K | -5K | -5K | -12K | -17K | -121K | -121K | -144K | -149K | -51K | -52K | -30K | -15K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -16.21M | -10.72M | -7.99M | -7.28M | -7.15M | -6.38M | -7.11M | -8.11M | -9.06M | -10.06M | -10.75M | -11.09M | -11.72M | -11.39M | -12.25M | -12.02M | -11.38M | -12.21M | -11.91M | -12.06M | -11.15M | -9.91M |
Add to Watchlist
Select watchlists to add or remove PHIO